Free Access
Med Sci (Paris)
Volume 35, Number 12, Décembre 2019
Anticorps monoclonaux en thérapeutique
Page(s) 1204 - 1205
Section Les acteurs de l’hexagone
Published online 06 January 2020
  1. Watiez D, Watier H. Anticorps thérapeutiques: la recherche française s’organise. Med Sci (Paris) 2009 ; 25: 1189–1191. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Pèlegrin A, Daguet A, Watier H. MAbImprove: a French Laboratoire d’excellence (LabEx) dedicated to therapeutic antibodies. MAbs 2014 ; 6: 803–804. [Google Scholar]
  3. Guillon-Munos A, Daguet A, Watier H. Antibody biosimilars: fears or opportunities? First LabEx MAbImprove industrial workshop, May 28, 2013, Tours. France. MAbs 2014 ; 6: 805–809. [Google Scholar]
  4. Bodier-Montagutelli E, Respaud R, Watier H, Guillon-Munos A. MAbDelivery: administration routes for antibody therapy third labEx MAbImprove industrial workshop, July 2, 2015 Tours. France. MAbs 2017 ; 9: 579–585. [Google Scholar]
  5. Martin C, Kizlik-Masson C, Pèlegrin A, et al. Antibody-drug conjugates: design and development for therapy and imaging in and beyond cancer, labEx MAbImprove industrial workshop, July 27–28, 2017, Tours. France. MAbs 2018 ; 10: 210–221. [CrossRef] [PubMed] [Google Scholar]
  6. Martineau P, Watier H, Pèlegrin A, Turtoi A. Targets for MAbs: innovative approaches for their discovery and validation, labEx MAbImprove 6th antibody industrial symposium, June 25–26, 2018, Montpellier. France. MAbs 2019 ; 11: 812–825. [CrossRef] [PubMed] [Google Scholar]
  7. Le Larivière M.. club anticorps thérapeutiques de la SFI. Med Sci (Paris) 2019 ; 35: 1206–1207. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. Pons D, Pontremoli R, Vuddamalay G, et al. Description des acteurs français issus du Programme d’investissement d’avenir: le rôle de MabDesign. Med Sci (Paris) 2019 ; 35: 1198–1201. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.